NCT04994990

Effective OnabotulinumtoxinA Dose Response Study for Upper Facial Wrinkles

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Northwell Health · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This research is being done to determine if lower doses of botox than what is currently recommended can give similar results to patients, at lower cost and lower risk to them. Subjects will receive botox in the same areas of the upper face with standard doses on one side of the face. On the other side, double the botox concentration will be administered, free of charge to the participant, in order to see if the difference in concentration creates a difference in wrinkle reduction and participant satisfaction over time.

Conditions

• Rhytides

Interventions

Type	Name	Description
DRUG	OnabotulinumtoxinA Standard Dose	Active comparator group will be treated for full upper face wrinkles with standard recommended doing of onabotulinumtoxinA
DRUG	OnabotulinumtoxinA Half Standard Dose	Experimental group will be treated for full upper face wrinkles with half of the standard recommended doing of onabotulinumtoxinA

Timeline

• Start date: 2023-05-25
• Primary completion: 2024-11-30
• Completion: 2025-05-30
• First posted: 2021-08-06
• Last updated: 2023-10-16